Literature DB >> 25769369

Hippocampal serotonin depletion is related to the presence of generalized tonic-clonic seizures, but not to psychiatric disorders in patients with temporal lobe epilepsy.

Natascha C da Fonseca1, Helena P G Joaquim2, Leda L Talib2, Silvia de Vincentiis3, Wagner F Gattaz2, Kette D Valente4.   

Abstract

OBJECTIVE: Previous studies suggest that concentration of serotonin ([5-HT]) plays a pathogenic role in various types of epilepsy inhibiting seizures. However, most have not considered the clinical variables of epilepsy, and all of these studies included small and heterogeneous samples with refractory epilepsy, regardless of etiology. In this work, we measured [5-HT]s in hippocampal tissues from a large series of patients with refractory temporal lobe epilepsy caused by hippocampal sclerosis who underwent epilepsy surgery and evaluated the relationship between [5HT] and epilepsy-related clinical variables and psychiatric disorders.
METHODS: We included 44 patients with refractory unilateral TLE-HS who underwent surgical treatment for epilepsy. Hippocampal samples were collected, and serotonin concentrations were measured with high-pressure liquid chromatography (HPLC).
RESULTS: Lower [5-HT]s were correlated with a history of GTC seizures (Student's t-test: p 0.041). There were no differences in [5-HT]s according to the other clinical variables and the presence of psychiatric disorders. SIGNIFICANCE: Our findings demonstrated that serotonin depletion in the hippocampus play an important role in some aspects of the severity of epilepsy (i.e., the presence of GTC seizures) in a homogeneous sample of patients with refractory temporal lobe epilepsy determined by hippocampal sclerosis, but not with the presence of psychiatric disorders.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25769369     DOI: 10.1016/j.eplepsyres.2014.12.013

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  6 in total

Review 1.  Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome.

Authors:  An-Sofie Schoonjans; Lieven Lagae; Berten Ceulemans
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

Review 2.  Serotonin and sudden unexpected death in epilepsy.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Benton S Purnell; Gordon F Buchanan
Journal:  Exp Neurol       Date:  2019-12-19       Impact factor: 5.330

Review 3.  Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Authors:  Dubravka Svob Strac; Nela Pivac; Ilse J Smolders; Wieslawa A Fogel; Philippe De Deurwaerdere; Giuseppe Di Giovanni
Journal:  Front Neurosci       Date:  2016-11-10       Impact factor: 4.677

4.  Immunoreactivity of Muscarinic Acetylcholine M2 and Serotonin 5-HT2B Receptors, Norepinephrine Transporter and Kir Channels in a Model of Epilepsy.

Authors:  Enes Akyuz; Zuleyha Doganyigit; Yam Nath Paudel; Betul Koklu; Emin Kaymak; Chiara Villa; Alina Arulsamy; Mohd Farooq Shaikh; Orrin Devinsky
Journal:  Life (Basel)       Date:  2021-03-26

Review 5.  Serotonin receptors in epilepsy: Novel treatment targets?

Authors:  Jo Sourbron; Lieven Lagae
Journal:  Epilepsia Open       Date:  2022-02-02

6.  Serotonin transporter in the temporal lobe, hippocampus and amygdala in SUDEP.

Authors:  Smriti Patodia; Alyma Somani; Joan Liu; Alice Cattaneo; Beatrice Paradiso; Maria Garcia; Muhammad Othman; Beate Diehl; Orrin Devinsky; James D Mills; Jackie Foong; Maria Thom
Journal:  Brain Pathol       Date:  2022-04-27       Impact factor: 7.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.